Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sep 1, 2010

Premium

PrimeraDx said this week that it has appointed Matthew McManus as president and CEO.

McManus, who will also join PrimeraDx's board of directors, was previously head of Cleveland Clinic Laboratories and COO of the Pathology and Laboratory Medicine Institute. Prior to this, he was a medical scientist for the Novartis Institutes for Biomedical Research Drug Discovery Incubator. He has also worked at McKinsey & Company and Proctor & Gamble. He holds an MD and PhD from the University of Pennsylvania School of Medicine and an MBA from Boston College.


HTG said this week that it has appointed John Wineman as vice president of new business development, western region; and Thomas Vasicek as vice president of clinical programs and product innovation.

Wineman will be responsible for commercial sales and new business growth for the western region of North America and Asia, HTG said. Prior to joining HTG, Wineman was director of business development for FEI's Life Science division. Prior to that, he serves as director of strategic marketing and director of corporate development for Roche Diagnostics' Ventana Medical Systems group.

Wineman has also worked for LifeSpan Biosciences, Becton-Dickinson, and Bio-Rad Laboratories. He holds an MBA from San Diego State University and a BS in biology from Oregon State University.

Vasicek will be responsible for leading HTG's clinical programs and establishing HTG's new assay innovation roadmap, HTG said. Prior to joining the company, Vasicek was senior director of medical innovation for Roche's Ventana Medical Systems group. Prior to that, he served as senior director of bioscience technology development at Medtronic.

Vasicek has also served as vice president of business development for Solexa/Lynx Therapeutics; CSO for LabSeek Scientific Collaboration; director of commercial technology for Corning's life sciences group; senior scientist at Millennium Pharmaceuticals; and a visiting scientist at the Whitehead Institute. He holds a PhD in genetics from Harvard University and completed his postdoc at Princeton University.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.